Difficulty: Medium
Average Score: 95%
Practice
In comparison to cimetidine, ranitidine:
Correct answer
B
Rationale
In comparing cimetidine and ranitidine in the context of drugs affecting the gastrointestinal system, it is important to understand their pharmacological properties and clinical implications. The correct answer, B) Is less likely to cause gynaecomastia, is based on the side effect profiles of these two drugs.
Ranitidine is a histamine-2 receptor antagonist like cimetidine, but it has a lower affinity for androgen receptors. Gynaecomastia, the development of breast tissue in males, is a known side effect of cimetidine due to its anti-androgenic effects. Ranitidine, on the other hand, has a reduced risk of causing this adverse effect, making option B the correct choice.
Option A, that ranitidine does not bind to androgen receptors, is incorrect as ranitidine does have some affinity for these receptors, albeit lower than cimetidine. Option C, that ranitidine penetrates the blood-brain barrier to a lesser extent, is also incorrect as both drugs have similar limited penetration of the blood-brain barrier. Option D, that ranitidine is not available for parenteral use, is incorrect as ranitidine is available in both oral and parenteral formulations.
In an educational context, understanding the differences between cimetidine and ranitidine is crucial for healthcare professionals prescribing medications for gastrointestinal disorders. Knowledge of their side effect profiles, mechanisms of action, and pharmacokinetic properties helps in making informed decisions to provide optimal patient care. This question highlights the importance of considering drug characteristics in clinical practice to minimize adverse effects and maximize therapeutic outcomes.
Ranitidine is a histamine-2 receptor antagonist like cimetidine, but it has a lower affinity for androgen receptors. Gynaecomastia, the development of breast tissue in males, is a known side effect of cimetidine due to its anti-androgenic effects. Ranitidine, on the other hand, has a reduced risk of causing this adverse effect, making option B the correct choice.
Option A, that ranitidine does not bind to androgen receptors, is incorrect as ranitidine does have some affinity for these receptors, albeit lower than cimetidine. Option C, that ranitidine penetrates the blood-brain barrier to a lesser extent, is also incorrect as both drugs have similar limited penetration of the blood-brain barrier. Option D, that ranitidine is not available for parenteral use, is incorrect as ranitidine is available in both oral and parenteral formulations.
In an educational context, understanding the differences between cimetidine and ranitidine is crucial for healthcare professionals prescribing medications for gastrointestinal disorders. Knowledge of their side effect profiles, mechanisms of action, and pharmacokinetic properties helps in making informed decisions to provide optimal patient care. This question highlights the importance of considering drug characteristics in clinical practice to minimize adverse effects and maximize therapeutic outcomes.